Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study shows.
Jan 25, 2022
0
15
Convalescent plasma therapy was one of the first treatments available in the battle against COVID-19. But since the therapy's emergency use authorization by the Food and Drug Administration in August 2020, its supposed benefits ...
Jan 19, 2022
0
26
Blood plasma from people recovering from COVID-19 could help prevent severe illness in older patients newly infected with the virus, a small new Argentinian study finds.
Jan 7, 2021
1
4
The pandemic has seen unprecedented global efforts to discover a safe and effective treatment, either by developing new medicines to target the novel coronavirus or repurposing existing drugs.
Oct 16, 2020
0
1
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in a clinical trial.
Aug 19, 2019
0
8
(HealthDay)—The use of plasma infusion therapies (often called "vampire" treatments, in which people undergo infusions of a young donor's blood) is on the rise across the United States, often costing thousands of dollars ...
Feb 20, 2019
0
0
Clinical researchers at Princess Margaret Cancer Centre have discovered why multiple myeloma, an incurable cancer of the bone marrow, persistently escapes cure by an initially effective treatment that can keep the disease ...
Sep 9, 2013
0
1
There is growing evidence that a gene variant that reduces the plasticity of the nervous system also modulates responses to treatments for mood and anxiety disorders. In this case, patients with posttraumatic stress disorder, ...
Jun 11, 2013
0
0
Wayne State University School of Medicine researchers, working with colleagues in Canada, have found that one or more substances produced by a type of immune cell in people with multiple sclerosis (MS) may play a role in ...
Jul 31, 2012
0
0
(Medical Xpress) -- Researchers from ETH Zurich have developed a procedure to test the clinical benefits of cancer biomarkers. The method could radically shorten the path from the lab to their application.
Jul 19, 2012
0
0
